Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy

Int J Gynaecol Obstet. 2004 Nov;87(2):178-9. doi: 10.1016/j.ijgo.2004.08.007.

Abstract

This case report illustrates the successful use of activated recombinant factor VIIa in the management of severe postpartum hemorrhage secondary to amniotic fluid embolism.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cesarean Section
  • Disseminated Intravascular Coagulation / complications
  • Disseminated Intravascular Coagulation / drug therapy*
  • Embolism, Amniotic Fluid / complications
  • Embolism, Amniotic Fluid / drug therapy*
  • Factor VII / administration & dosage
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Female
  • Humans
  • Infusions, Intravenous
  • Postpartum Hemorrhage / complications
  • Postpartum Hemorrhage / drug therapy*
  • Pregnancy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa